newsfilter
← Latest News
Business Wire·

Cybin to Participate in the Jefferies Global Healthcare Conference in London

Cybin Inc. (NYSE:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery platforms